A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: A pilot study

BMC Urology

Volumn 12, Issue , 2012, Pages

  Keay, Susan ^a,b   Leitzell, Samantha ^c   Ochrzcin, Ashley ^c   Clements, George ^c   Zhan, Min ^a   Johnson, David ^b,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Baltimore Res and Educ Foundation   (United States)

Author keywords

Interstitial cystitis; Mouse model; Painful bladder syndrome

Indexed keywords

ACETIC ACID; ASIALYLATED ANTIPROLIFERATIVE FACTOR; GLYCOPEPTIDE; PHOSPHATE BUFFERED SALINE; PROTEIN ANTIBODY; PROTEIN ZO1; PROTEIN ZO1 ANTIBODY; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; UROPLAKIN 3; UROPLAKIN 3 ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER EPITHELIUM; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMAGE ANALYSIS; IMMUNOFLUORESCENCE MICROSCOPY; IN VIVO STUDY; INTERSTITIAL CYSTITIS; MOUSE; NONHUMAN; PILOT STUDY; PROTEIN EXPRESSION; TISSUE REPAIR;

ANIMALS; CYSTITIS, INTERSTITIAL; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; GLYCOPROTEINS; MALE; MICE; MICE, INBRED CBA; PILOT PROJECTS; URINARY BLADDER;

EID: 84861954454     PISSN: None     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-12-17     Document Type: Article

References (58)

1. Clinical features and spectrum of light microscopic changes in interstitial cystitis. Johansson SL, Fall M, J Urol 1990 143 1118 1124 2342171
2. Critical notes: respective immune pathogenesis of interstitial cystitis. (article in German). Skoluda D, Wegner K, Lemmel EM, Urologe A 1974 13 15 23 4596210
3. Biopsy features are associated with primary symptoms in interstitial cystitis: results from the Interstitial cystitis database study. Tomaszewski JE, Landis JR, Russack V, Williams TM, Wang LP, Hardy C, Brensinger C, Matthews YL, Abele ST, Kusek JW, Nyberg LM, Interstitial Cystitis Database Study, Interstitial Cystitis Database Study, Urology 2001 57 67 81 10.1016/S0090- 4295(01)01166-9 11378053
4. Chronic ulcerating interstitial cystitis (Hunners ulcer). Smith BH, Dehner LP, Arch Pathol 1972 93 76 81 5007000
5. The etiology of interstitial cystitis. Ratliff TL, Klutke CG, McDougall EM, Urology Clinics of North America 1994 21 21 30
6. Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. Slobodov G, Feloney M, Gran C, Kyker KD, Hurst RE, Culkin DJ, J Urol 2004 171 1554 1558 10.1097/01.ju.0000118938.09119.a5 15017219
7. MicroRNAs may mediate the down-regulation of neurokinin-1 receptor in chronic bladder pain syndrome. Sanchez Freire V, Burkhard FC, Kessler TM, Kuhn A, Draeger A, Monastyrskaya K, Am J Pathol 2010 176 288 303 10.2353/ajpath.2010. 090552 20008142
8. Evidence for urothelial cell activation in interstitial cystitis. Liebert M, Wedemeyer G, Stein JA, Washington R, Faerber G, Flint A, Grossman HB, J Urol 1993 149 470 475 8094760
9. Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis. Hauser PJ, Dozmorov MG, Bane BL, Slobodov G, Culkin DJ, Hurst RE, J Urol 2008 179 764 769 18082196
10. Keratin expression profiling of transitional epithelium in the painful bladder syndrome/interstitial cystitis. Laguna P, Smedts F, Nordling J, Horn T, Bouchelouche K, Hopman A, de la Rosette J, Am J Clin Pathol 2006 125 105 110 16482998
11. P2X and P2X receptor expression in human bladder urothelium and changes in interstitial cystitis. Tempest HV, Dixon AK, Turner WH, Elneil S, Sellers LA, Ferguson DR, Br J Urol Int 2004 93 1344 1348 10.1111/j.1464-410X.2004.04858.x
12. Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis. Koskela LR, Thiel T, Ehren I, De Verdier PJ, Wiklund NP, J Urol 2008 180 737 741 10.1016/j.juro.2008.03.184 18554637
13. Decreased in vitro proliferation of bladder epithelial cells from patients with interstitial cystitis. Keay S, Zhang C-O, Shoenfelt JL, Chai TC, Urology 2003 61 1278 1284 10.1016/S0090-4295(03)00005-0 12809929
14. Changes in human bladder cell gene expression associated with interstitial cystitis or antiproliferative factor treatment. Keay S, Seillier-Moiseiwitsch F, Zhang C-O, Chai TC, Zhang J, Physiol Genomics 2003 14 107 115 12847144
15. Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from patients with interstitial cystitis. Zhang CO, Wang JY, Koch KR, Keay S, J Urol 2005 174 2382 2387 10.1097/01.ju.0000180417.11976.99 16280852
16. Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production. Keay S, Kleinberg M, Zhang C-O, Hise MK, Warren JW, J Urol 2000 164 2112 2118 10.1016/S0022-5347(05)66980-7 11061938
17. A deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitis. Hurst RE, Roy JB, Min KW, Veltri RW, Marley G, Patton K, Shackelford DL, Stein P, Parsons CL, Urology 1996 48 817 821 10.1016/S0090-4295(96)00322-6 8911536
18. Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis. Hurst RE, Moldwin RM, Mulholland SG, Urology 2007 69 Suppl 4A 17 23 17462475
19. Differentiation potential of urothelium from patients with benign bladder dysfunction. Southgate J, Varley CL, Garthwaite MA, Hinley J, Marsh F, Stahlschmidt J, Trejdosiewicz LK, Eardley I, BJU Int 2007 99 1506 1516 10.1111/j.1464-410X.2007.06795.x 17537219
20. Up-regulation of P2X3 receptor during stretch of bladder urothelial cells from patients with interstitial cystitis. Sun Y, Chai TC, J Urol 2004 17 448 452
21. Characterization of cyclophosphamide cystitis, a model of visceral and referred pain, in the mouse: species and strain differences. Bon K, Lichtensteiger CA, Wilson SG, Mogil JS, J Urol 2003 170 1008 1012 10.1097/01.ju.0000079766.49550.94 12913760
22. Models of inflammation of the lower urinary tract. Bjorling DE, Wang Z-Y, Bushman W, Neurourol Urodyn 2011 30 673 682 10.1002/nau.21078 21661012
23. Altered inducible nitric oxide synthase expression and nitric oxide production in the bladder of cats with feline interstitial cystitis. Birder LA, Wolf-Johnston A, Buffington CA, Roppolo JR, de Groat WC, Kanai AJ, J Urol 2005 173 625 629 10.1097/01.ju.0000145900.22849.1d 15643277
24. Urothelial lesion formation is mediated by TNFR1 during neurogenic cystitis. Chen MC, Mudge CS, Klumpp DJ, Am J Physiol Renal Physiol 2006 291 741 F749 10.1152/ajprenal.00081.2006 16622179
25. Intravesical protamine sulfate and potassium chloride as a model for bladder hyperactivity. Chuang Y-C, Chancellor MB, Seki S, Yoshimura N, Tyagi P, Huang L, Lavelle JP, De Groat WC, Fraser MO, Urology 2003 61 664 670 10.1016/S0090-4295(02)02280-X 12639680
26. A reliable, nondestructive animal model for interstitial cystitis: intravesical low-dose protamine sulfate combined with physiological concentrations of potassium chloride. Fraser MO, Chuang Y-C, Lavella JP, Yoshimura N, de Groat WC, Chancellor MB, Urology 2001 57 6 Suppl 1 112 11378083
27. Nerve growth factor mediates peripheral mechanical hypersensitivity that accompanies experimental cystitis in mice. Guerios SD, Wang Z-Y, Bjorling DE, Neurosci Lett 2006 392 193 197 10.1016/j.neulet.2005.09.026 16203088
28. Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate. Hauser PJ, Buethe DA, Califano J, Sofinowski TM, Culkin DJ, Hurst RE, J Urol 2009 182 2477 2482 10.1016/j.juro.2009.07.013 19765766
29. Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid. Kirimoto T, Nakano K, Irimura K, Hayashi Y, Matsuura N, Kiniwa M, Oka T, Yoshimura N, BJU Int 2007 100 935 939 10.1111/j.1464-410X.2007.07044.x 17714534
30. Bladder permeability barrier: recovery from selective injury of surface epithelial cells. Lavelle J, Meyers S, Ramage R, Bastacky S, Doty D, Apodaca G, Zeidel ML, Am J Physiol Renal Physiol 2002 283 242 F253 12110507
31. Lower urinary tract phenotype of experimental autoimmune cystitis in mouse: a potential animal model for interstitial cystitis. Lin Y-H, Liu G, Kavran M, Altuntas CZ, Gasbarro G, Tuohy VK, Daneshgari F, BJU Int 2008 102 1724 1730 10.1111/j.1464-410X.2008.07891.x 18710451
32. RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model. Liu W, DeYoung BR, Chen X, Evanoff DP, Luo Y, J Autoimmun 2008 30 257 265 10.1016/j.jaut.2007.10.005 18162370
33. Ice water testing reveals hypersensitivity in adult rats that experienced neonatal bladder inflammation: implications for painful bladder syndrome/interstitial cystitis. Randich A, Mebane H, Ness TJ, J Urol 2009 182 337 342 10.1016/j.juro.2009.02.107 19447422
34. Urine is necessary to provoke bladder inflammation in protamine sulfate induced urothelial injury. Soler R, Bruschini H, Freire MP, Alves MT, Srougi M, Ortiz V, J Urol 2008 180 1527 1531 10.1016/j.juro.2008.06.006 18710775
35. In vivo models of interstitial cystitis. Westropp JL, Buffington CA, J Urol 2002 167 2 Pt 1 694 702 11792956
36. An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. Keay SK, Szekely Z, Conrads TP, Veenstra TD, Barchi JJ, Zhang C-O, Koch KR, Michejda CJ, Proc Natl Acad Sci, USA 2004 101 11803 11808 10.1073/pnas.0404509101 15282374
37. New theories in interstitial cystitis. Chai TC, Keay S, Nat Clin Pract Urol 2004 1 85 89 10.1038/ncpuro0057 16474520
38. Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Keay S, Zhang C-O, Shoenfelt J, Erickson DE, Whitmore K, Warren JW, Marvel R, Chai T, Urology 2001 57 6 Suppl 1 9 14 11378043
39. Prospective evaluation of candidate urine and cell markers in patients with interstitial cystitis enrolled in a randomized clinical trial of Bacillus Calmette Guerin (BCG). Keay S, Reeder J, Koch K, Zhang C-O, Grkovic D, Peters K, Zhang Y, Kusek JW, Nyberg LM, Payne CK, Propert K, the Interstitial Cystitis Clinical Trials Group (ICCTG), the Interstitial Cystitis Clinical Trials Group (ICCTG), World J Urol 2007 25 499 504 10.1007/s00345-007-0205-4 17694391
40. A diagnostic in vitro assay for interstitial cystitis. Keay S, Zhang C-O, Hise MK, Hebel JR, Jacobs SC, Gordon D, Whitmore K, Bodison S, Gordon N, Warren JW, Urology 1998 52 6 974 978 10.1016/S0090-4295(98)00488-9 9836539
41. Antiproliferative activity is present in bladder but not renal pelvic urine from interstitial cystitis patients. Keay S, Warren JW, Zhang C-O, Tu LM, Gordon DA, Whitmore KE, J Urol 1999 162 1487 1489 10.1016/S0022-5347(05)68345-0 10492242
42. Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African American and caucasian American patients with interstitial cystitis. Zhang C-O, Li Z-L, Shoenfelt JL, Kong C-Z, Chai TC, Erickson DE, Peters KM, Rovner ES, Keay S, Urology 2003 61 897 901 10.1016/S0090-4295(02) 02597-9 12735999
43. Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis vs. chronic pelvic pain syndrome. Keay S, Zhang C-O, Chai T, Warren J, Koch K, Grkovic D, Colville H, Alexander R, Urology 2004 63 22 26 10.1016/j.urology. 2003.08.024 14751340
44. Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells. Shahjee HM, Koch KR, Guo L, Zhang C-O, Keay S, J Exp Clin Cancer Res 2010 29 160 170 10.1186/1756-9966-29- 160 21143984
45. p53 mediates interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human urothelial cells. Kim J, Keay SK, Dimitrakov JD, Freeman MR, FEBS Lett 2007 581 3795 3799 10.1016/j.febslet.2007.06.058 17628545
46. The effect of novel frizzled 8-related antiproliferative factor on in vitro carcinoma and melanoma cell proliferation and invasion. Koch KR, Zhang CO, Kaczmarek P, Barchi J Jr, Gou L, Shahjee HM, keay S, Invest new drugs 2007
47. Urinary tract infection and inflammation at onset of interstitial cystitis/painful bladder syndrome. Warren JW, Brown V, Jacobs S, Horne L, Langenberg P, Greenberg P, Urology 2008 71 1085 1090 10.1016/j.urology.2007.12. 091 18538691
48. Bladder cytopathic effects associated with Gram-negative bacterial genera. Davis CP, Current Microbiol 1981 6 37 42 49 10.1007/BF01566724
49. Effects of sodium hyaluronate on epithelial healing of the vesical mucosa and vesical fibrosis in rabbits with acetic acid induced cystitis. Takahashi K, Takeuchi J, Takahashi T, Miyauchi S, Horie K, Uchiyama Y, J Urol 2001 166 710 713 10.1016/S0022-5347(05)66048-X 11458122
50. Protective effects of lithium on acetic acid-induced colitis in the rat. Daneshmand A, Rahimian R, Mohammadi H, Ejtemaee-Mehr S, Tavangar SM, Kelishomi RB, Dehpour AR, Dig Dis Sci 2009 54 1901 7 10.1007/s10620-008-0569-3 19082724
51. Urothelial pathophysiological changes in feline interstitial cystitis: a human model. Lavelle JP, Meyers SA, Ruiz WG, Buffington CA, Zeidel ML, Apodaca G, Am JPhysiol Renal Physiol 2000 278 540 F553
52. The ameliorating effect of melatonin on protamine sulfate induced bladder injury and its relationship to interstitial cystitis. Cetinel S, Ercan F, Sirvanci S, Sehirli O, Ersoy Y, San T, Sener G, J Urol 2003 169 1564 8 10.1097/01.ju.0000049649.80549.17 12629416
53. Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Birder LA, Ruan HZ, Chopra B, Xiang Z, Barrick S, Buffington CA, Roppolo JR, Ford AP, de Groat WC, Burnstock G, Am J Physiol Renal Physiol 2004 287 1084 91 10.1152/ajprenal.00118.2004 15251862
54. Acute acrolein-induced cystitis in mice. Bjorling DE, Elkahwaji JE, Bushman W, Janda LM, Boldon K, Hopkins WJ, Wang Z-Y, BJU Int 2007 99 1523 9 10.1111/j.1464-410X.2007.06773.x 17346276
55. Expressions of uroplakins in the mouse urinary bladder with cyclophosphamide-induced cystitis. Choi SH, Byun Y, Lee G, J Korean Med Sci 2009 24 684 9 10.3346/jkms.2009.24.4.684 19654953
56. Expression of nitric oxide synthase and aquaporin-3 in cyclophosphamide treated rat bladder. Cho KH, Hyun JH, Chang YS, Na YG, Shin JH, Song KH, Int Neurourol J 2010 14 149 56 10.5213/inj.2010.14.3.149 21179332
57. Cystitis, co-morbid disorders and associated epithelial dysfunction. Birder LA, Hanna-Mitchell AT, Mayer E, Buffington CA, Neurourol Urodyn 2011 30 668 72 10.1002/nau.21109 21661011
58. A hypothesis for the etiology of interstitial cystitis based upon inhibition of bladder epithelial repair. Keay S, Warren JW, Med Hypotheses 1998 51 79 83 10.1016/S0306-9877(98)90260-2 9881843